{"id":"W2294307578","doi":"10.1093/annonc/mdw098","title":"Long-term outcomes after adjuvant treatment of sequential versus combination docetaxel with doxorubicin and cyclophosphamide in node-positive breast cancer: BCIRG-005 randomized trial","year":2016,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":63,"is_retracted":false,"has_abstract":false,"ca_institutions":"Translational Research in Oncology; Université Laval; Brampton Civic Hospital; Ontario Institute for Cancer Research","funders":"Pfizer; Halozyme; GlaxoSmithKline; Amgen","keywords":"Medicine; Docetaxel; Cyclophosphamide; Breast cancer; Regimen; Internal medicine; Febrile neutropenia; Oncology; Metastatic breast cancer; Chemotherapy; Neutropenia; Doxorubicin; Surgery; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001399636,0.0002219718,0.0008439965,0.0000723223,0.00002367013,0.000003341209,0.00006533989,0.0001335857,0.00002314638],"category_scores_gemma":[0.00002853055,0.0001314706,0.0001404327,0.00005646439,0.0004350192,0.00001071029,0.00005154655,0.00002645732,7.374506e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00008637879,"about_ca_system_score_gemma":0.0001611112,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007359752,"about_ca_topic_score_gemma":0.001482907,"domain_scores_codex":[0.9987813,0.0001804703,0.000374565,0.0003193295,0.0001143532,0.0002299776],"domain_scores_gemma":[0.9991572,0.000182209,0.0002919173,0.0001748713,0.0001432254,0.00005057606],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8128692,0.001106973,0.1415655,0.00002007462,0.001153965,0.00002898117,0.0002217627,0.000004015013,0.004299467,0.00003324889,0.00002033795,0.03867647],"study_design_scores_gemma":[0.5806842,0.003133368,0.3717386,0.00007215521,0.0001938393,0.00001031373,0.00002149795,6.641381e-7,0.0439604,0.00002359109,0.00003067127,0.0001306404],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9939023,0.001922066,0.00002960911,0.002783567,0.0002166726,0.0007281426,0.0002750762,0.000004317651,0.0001382563],"genre_scores_gemma":[0.9940161,0.005312188,0.00004357681,0.00009745146,0.00006689665,0.0003599703,0.00003676069,0.00001452424,0.00005250252],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.232185,"threshold_uncertainty_score":0.5361217,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0269477683234731,"score_gpt":0.3422365740486171,"score_spread":0.315288805725144,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}